My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

MoonLake Immunotherapeutics - Class A Ordinary Shares (NQ:MLTX)

15.62 -0.17 (-1.08%)

Streaming Delayed Price Updated: 10:10 AM EST, Feb 12, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about MoonLake Immunotherapeutics - Class A Ordinary Shares

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Why Credo Technology Group Shares Are Trading Higher By Over 14%; Here Are 20 Stocks Moving Premarket ↗

June 03, 2025

Via Benzinga

US Stocks Likely To Open Lower: Expert Highlights Technical Analysis Showing S&P 500's 'Recovery Is Real' And Not A 'Bull Trap' Or 'Bear Market Rally' ↗

June 03, 2025

U.S. stock futures fell on Tuesday after a higher close on Monday. Futures of major benchmark indices declined in premarket.

Via Benzinga

Topics Stocks

Dollar General, Signet Jewelers And 3 Stocks To Watch Heading Into Tuesday ↗

June 03, 2025

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

June 02, 2025

Via Benzinga

Expert Ratings for MoonLake ↗

November 27, 2023

Via Benzinga

Recap: MoonLake Q3 Earnings ↗

November 14, 2023

Via Benzinga

16 Analysts Have This to Say About MoonLake ↗

November 07, 2023

Via Benzinga

This West Pharmaceutical Services Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday ↗

March 18, 2025

Via Benzinga

Goldman Sachs Thinks Mid-Cap Biotech MoonLake Could Soar Over 80%: Is Retail Watching Closely? ↗

January 17, 2025

Oppenheimer has included MoonLake among its top biotech picks for 2025, alongside Capricor, Gilead, Kymera, Praxis, and Prothena.

Via Stocktwits

MoonLake initiates three new clinical trials and further expands the portfolio of indications for the Nanobody® sonelokimab

January 08, 2025

From MoonLake Immunotherapeutics AG

Via GlobeNewswire

MoonLake Immunotherapeutics Announces Positive Regulatory Feedback from both FDA and EMA on Path for the Phase 3 Program for the Nanobody® sonelokimab in Psoriatic Arthritis

June 10, 2024

From MoonLake Immunotherapeutics AG

Via GlobeNewswire

MoonLake Immunotherapeutics starts Phase 3 VELA program of the Nanobody® sonelokimab in patients with moderate-to-severe hidradenitis suppurativa

May 16, 2024

From MoonLake Immunotherapeutics AG

Via GlobeNewswire

Why Diodes Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

May 10, 2024

Via Benzinga

MLTX Stock Earnings: MoonLake Misses EPS for Q1 2024 ↗

May 07, 2024

MLTX stock results show that MoonLake missed analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

MoonLake Immunotherapeutics Inks Three-Year Technology Partnership With Komodo Health To Advance Research on Inflammatory Skin and Joint Conditions

April 10, 2024

From Komodo Health

Via Business Wire

MoonLake Jumps After Arthritis Drug Tops AbbVie Blockbuster Humira In A Key Test ↗

March 11, 2024

The company tested its psoriatic arthritis drug over 24 weeks against Humira.

Via Investor's Business Daily

Why Is Inflammatory Disease-Focused MoonLake Immunotherapeutics Stock Trading Higher Today? ↗

March 11, 2024

Results with MoonLake Immunotherapeutics' Nanobody sonelokimab in Psoriatic Arthritis. Achieve over 60% ACR50, 40% ACR70, and 80% PASI90 by week 24. Unprecedented improvements compared to competitors.

Via Benzinga

MoonLake announces significant improvements with Nanobody® sonelokimab over 24 weeks in active psoriatic arthritis (PsA) and other important updates at its R&D Day

March 10, 2024

From MoonLake Immunotherapeutics AG

Via GlobeNewswire

MoonLake Immunotherapeutics to present MIRA trial data of Nanobody® sonelokimab in hidradenitis suppurativa as a late breaker at the AAD Annual Meeting 2024

March 04, 2024

From MoonLake Immunotherapeutics AG

Via GlobeNewswire

Cooper Companies Reports Upbeat Results, Joins Dell, NetApp, Tidewater And Other Big Stocks Moving Higher On Friday ↗

March 01, 2024

U.S. stocks were higher, with the Nasdaq Composite gaining around 0.5% on Friday.

Via Benzinga

Topics Stocks

MoonLake Immunotherapeutics Announces Positive Feedback from both FDA and EMA on Regulatory Path for the Phase 3 Program of the Nanobody® sonelokimab (SLK) in Hidradenitis Suppurativa (HS)

February 26, 2024

From MoonLake Immunotherapeutics AG

Via GlobeNewswire

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

December 20, 2023

Via Benzinga

Why Former Highflier MoonLake Plummeted 29% After A Recent Run ↗

November 06, 2023

The company tested its drug over 12 weeks in 207 patients. All but one regimen led to statistically significant improvements.

Via Investor's Business Daily

Dow Turns Lower; EchoStar Shares Plunge ↗

November 06, 2023

U.S. stocks turned lower toward the end of trading, with the Dow Jones falling around 50 points on Monday The Dow traded down 0.16% to 34,007.81 while the NASDAQ fell 0.08% to 13,467.42. The S&P 500...

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Monday's Intraday Session ↗

November 06, 2023

Via Benzinga

Crude Oil Moves Higher; BioNTech Lowers 2023 Sales Outlook ↗

November 06, 2023

U.S. stocks traded higher midway through trading, with the Dow Jones gaining around 40 points on Monday The Dow traded up 0.13% to 34,106.99 while the NASDAQ rose 0.16% to 13,499.42. The S&P 500 also...

Via Benzinga

Topics Stocks

Why Bluegreen Vacations Shares Are Trading Higher By Around 105%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

November 06, 2023

Gainers Carbon Revolution Public Limited (NASDAQ: CREV) shares jumped 396.2% to $145.49 after gaining 100% on Friday. The company’s stock began trading on Friday following merger with Twin Ridge...

Via Benzinga

Why Is Arthritis-Focused MoonLake Immunotherapeutics Stock Trading Lower Today? ↗

November 06, 2023

Sunday, MoonLake Immunotherapeutics (NASDAQ: MLTX) released topline results from its global Phase 2 ARGO trial of Nanobody sonelokimab in patients with

Via Benzinga

TreeHouse Foods, EchoStar, Hilton Grand Vacations, EchoStar And Other Big Stocks Moving Lower On Monday ↗

November 06, 2023

U.S. stocks traded higher, with the Dow Jones gaining around 25 points on Monday. Here are some big stocks recording losses in today’s session.

Via Benzinga

Topics Stocks

US Stocks Rise; Nasdaq Gains 50 Points ↗

November 06, 2023

U.S. stocks traded higher this morning, with the Nasdaq Composite gaining around 50 points on Monday Following the market opening Monday, the Dow traded up 0.21% to 34,133.62 while the NASDAQ rose...

Via Benzinga

Topics Stocks

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.